Document is current
Any future updates will be listed below
-
Authors
Uematsu, Miyuki
Miyamoto, Yuko
Shimizu, Masatake
Kajiura, Tsuyoshi
Saito, Atsushi
Takashina, Masaki
Fujita, Satoshi
Nakano, Yuko
Shimizu, Toshiaki
Nagahara, Yuki
Kosaka, Hayato
Muramatsu, Hiroki
Mori, Masafumi
Suzuki, Takamasa
Nakamura, Takayoshi
Tanemura, Atsushi
Hosaka, Junki
Mori, Takahide
Kato, Seiichi
Itagaki, Ayaka
Inoue, Toshiki
Matsumoto, Shinichi
Naito, Tomoko
Fujii, Shinji
Nakaoka, Ryusuke
Yamamoto, Eiichi
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22mk0102174)
- License Information
-
More Information
Article History
Received: 28 December 2023
Accepted: 9 September 2024
First Online: 20 September 2024
Competing interests
: The authors declare no competing interests.
: This study focused primarily on comparing the methodologies for protein quantification/residual protein recovery and included human handlers who solely operated the equipment and were not involved in clinical procedures or specimen collection. Given the absence of direct human involvement beyond equipment operation and clinical data or specimens, the nature and scope of the study did not necessitate human ethics clearance. As commercially purchased animal blood was used in the study, approval was not required by the Committee for Proper Experimental Animal Use and Welfare, a peer review panel established at National Institute of Health Sciences. Consequently, there were no ethical parameters, ethics approval, or informed consent issues related to human or animal experimentation.
